Abiopharma

News list

📋 David Kirske (Officer) plans to sell 17K shares of X4 Pharmaceuticals, Inc. (at $4.29 each, total $73K) Filed: May 12, 2026 | ID: 000004

Full text

News bot May 12, 2026, 10:11 p.m.
📋 Form 144 Filing: David Kirske

Company: X4 Pharmaceuticals, Inc.

Filing Date: 2026-05-12

Relationship: Officer
Planned Sale Details:
- Security: Common Stock
- Shares to be Sold: 16,961
- Price per Share: $4.29
- Total Value: $72,820.41
- Planned Sale Date: 2026-05-12
- Broker: Morgan Stanley Smith Barney LLC
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-38295
- Issuer Contact Phone: 508-633-4447
- Issuer Address: 61 NORTH BEACON STREET, 4TH FLOOR, BOSTON, MA, 02134
- Broker Address: New York Plaza, 38th Floor, New York, NY, 10004
- Shares Outstanding: 94319696.0
- Number of Securities to be Sold: 1
- Signature: /s/ Mitch Buckley as attorney-in-fact for David Kirske